Sage Mountain Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,782
Closed -$625K 382
2025
Q4
$625K Sell
1,782
-66
-4% -$22.3K 0.03% 240
2025
Q3
$597K Buy
1,848
+285
+18% +$88.6K 0.03% 233
2025
Q2
$608K Sell
1,563
-26
-2% -$10.5K 0.04% 210
2025
Q1
$691K Buy
1,589
+340
+27% +$136K 0.05% 170
2024
Q4
$461K Sell
1,249
-333
-21% -$139K 0.03% 224
2024
Q3
$822K Sell
1,582
-43
-3% -$23K 0.07% 132
2024
Q2
$880K Buy
1,625
+473
+41% +$250K 0.08% 108
2024
Q1
$597K Buy
1,152
+97
+9% +$48.2K 0.06% 135
2023
Q4
$497K Buy
1,055
+113
+12% +$52.3K 0.06% 131
2023
Q3
$410K Sell
942
-53
-5% -$24K 0.06% 142
2023
Q2
$442K Buy
995
+35
+4% +$16.1K 0.06% 125
2023
Q1
$441K Buy
+960
New +$457K 0.07% 116
2022
Q3
Sell
-472
Closed -$228K 388
2022
Q2
$228K Sell
472
-145
-24% -$71.7K 0.04% 399
2022
Q1
$303K Sell
617
-32
-5% -$14.6K 0.05% 382
2021
Q4
$301K Buy
649
+66
+11% +$27.8K 0.04% 438
2021
Q3
$217K Sell
583
-34
-6% -$12.9K 0.03% 421
2021
Q2
$236K Buy
+617
New +$236K 0.04% 359

Other funds holding ELV

Sage Mountain Advisors's ELV Position: Q1 2026 in Review

Sage Mountain Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,782 shares — an estimated $625K sold.

Sage Mountain Advisors first reported a position in ELV in Q2 2021 and held it in 17 quarters. The position peaked at $880K in Q2 2024. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Sage Mountain Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Sage Mountain Advisors sold 1,782 Elevance Health shares in Q1 2026, an estimated $625K.
  • Sage Mountain Advisors first reported a position in Elevance Health in Q2 2021 and held it in 17 quarters.
  • Sage Mountain Advisors's Elevance Health position peaked at $880K in Q2 2024.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Sage Mountain Advisors's 13F filing for Q1 2026, filed 11 May 2026.